Musculoskeletal Pain
📧 Sign up to get email alerts when something new happens for Musculoskeletal Pain.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-01-06FDA Approved: DULOXETINE — Original Application (Quallent Pharmaceuticals Health LLC)
FDA approved an Original Application (ANDA 208706) for duloxetine from Quallent Pharmaceuticals Health LLC, establishing a generic version o…
-
FDA approval · 2017-01-04FDA Approved: CYMBALTA — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Cymbalta (duloxetine hydrochloride) from Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2016-11-29Clinical Trial Update: Vitamin D3 Effects on Musculoskeletal Symptoms With Use of Aromatase Inhibitors [Phase 2]
Phase 2 clinical trial evaluating the effect of Vitamin D3 on musculoskeletal symptoms in patients taking aromatase inhibitors; results comp…
-
CLINICAL_TRIALS trial_result · 2016-11-29Clinical Trial Update: Simulator of Pompage Technique for Physiotherapists [NA]
A clinical trial evaluating a Pompage technique simulator for physiotherapists has completed, studying its use for musculoskeletal pain and …
-
FDA approval · 2016-11-22FDA Approved: METAXALONE — Original Application (Lannett Company, Inc.)
FDA approved the original ANDA for metaxalone (METAXALONE) filed by Lannett Company, Inc., establishing a generic product.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-09-23Clinical Trial Update: Individually Tailored Web-based Multimodal Pain Rehabilitation in Primary Health Care [NA]
A completed clinical trial evaluating an individually tailored web-based multimodal pain rehabilitation program in primary care for musculos…
-
CLINICAL_TRIALS research · 2016-09-23Clinical Trial Update: Interactive Web-based Program and CBT-coaching With Physiotherapy for Patients With Chronic Musculoskeletal Pain [NA]
An update on a clinical trial evaluating an interactive web-based program with CBT coaching plus physiotherapy for chronic musculoskeletal p…
-
CLINICAL_TRIALS trial_result · 2016-08-22Clinical Trial Update: Effective Methods of Reducing Lower Back, Neck and Shoulder Pain Among Office Workers [Phase 1]
A Phase 1 clinical trial evaluating methods to reduce lower back, neck, and shoulder pain in office workers has completed.
-
FDA approval · 2016-08-03FDA Approved: DULOXETINE — Original Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' original application for a generic duloxetine product. Duloxetine is used to treat multiple conditi…
-
FDA approval · 2016-06-24FDA Approved: CHLORZOXAZONE — Original Application (Solubiomix)
FDA approves the Original Application for chlorzoxazone, a generic muscle relaxant manufactured by Solubiomix, for short-term relief of musc…
-
FDA approval · 2016-05-25FDA Approved: CYCLOBENZAPRINE HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for cyclobenzaprine hydrochloride from Amneal Pharmaceuticals of New York LLC. This update confi…
-
CLINICAL_TRIALS research · 2015-11-16Clinical Trial Update: Multicomponent Program for the Integrated Management of Chronic Pain and Depression in Primary Care [NA]
Clinical trial update for a multicomponent program to manage chronic pain and depression in primary care; current status is unknown.
-
FDA approval · 2015-10-28FDA Approved: ALEVE PM — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application for ALEVE PM (diphenhydramine hydrochloride and naproxen sodium) to support its continued marketing …
-
FDA approval · 2015-10-28FDA Approved: DULOXETINE — Original Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' original ANDA for duloxetine, allowing a generic version to be marketed. The approval covers duloxetin…
-
CLINICAL_TRIALS trial_result · 2015-09-14Clinical Trial Update: Single Focused Shock Wave in the Release od Delayed Onset Muscle Soreness (DOMS) [NA]
A completed clinical trial evaluated the use of single focused shock wave therapy for delayed onset muscle soreness (DOMS) related to muscul…
-
FDA approval · 2015-08-26FDA Approved: DULOXETINE — Original Application (Ascend Laboratories, LLC)
The FDA approved Ascend Laboratories' original application for a generic duloxetine product (ANDA 203197), establishing a generic version of…
-
CLINICAL_TRIALS trial_result · 2015-08-20Clinical Trial Update: Investigation of Popular Recovery Techniques for Ultramarathon Recovery [NA]
A completed clinical trial evaluating popular recovery techniques for ultramarathon recovery in individuals with musculoskeletal pain.
-
CLINICAL_TRIALS trial_result · 2015-02-23Clinical Trial Update: Ultrasound Vs Nerve Stimulation - Why is a PNS so Effective? [NA]
A clinical trial comparing ultrasound with nerve stimulation for musculoskeletal pain has completed; the update discusses why peripheral ner…
-
CLINICAL_TRIALS trial_result · 2014-12-31Clinical Trial Update: Ibuprofen Versus Acetaminophen vs Their Combination in the Relief of Musculoskeletal Pain in the Emergency Setting [Phase 2]
A Phase 2 randomized trial comparing ibuprofen, acetaminophen, and their combination for relief of musculoskeletal pain in the emergency set…
-
CLINICAL_TRIALS trial_result · 2014-12-30Clinical Trial Update: Connective Tissue Motion Measure 2
The Connective Tissue Motion Measure 2 trial sponsored by Stromatec, Inc. has completed, studying low back pain and musculoskeletal pain.
-
CLINICAL_TRIALS trial_result · 2014-10-27Clinical Trial Update: Physiotherapy Assessment of Patients Referred to Orthopaedic Surgeon [NA]
A completed clinical trial update evaluating physiotherapy assessment for patients referred to orthopedic surgeons for musculoskeletal pain.
-
CLINICAL_TRIALS trial_result · 2014-10-10Clinical Trial Update: Treatment of Myofascial Pain Syndrome With Lidocaine Injection and Physical Therapy. [Phase 4]
Phase 4 clinical trial evaluating lidocaine injections with physical therapy for myofascial pain syndrome has completed and posted results.
-
FDA approval · 2014-09-26FDA Approved: DULOXETINE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for duloxetine from Zydus Lifesciences Limited under an ANDA. The approval involves changes to the a…
-
CLINICAL_TRIALS trial_result · 2014-08-20Clinical Trial Update: Integrative Coping Group for Children [NA]
Duke University completed a clinical trial evaluating an Integrative Coping Group for Children for childhood depression and anxiety, with da…
-
FDA approval · 2014-08-12FDA Approved: ROBAXIN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Robaxin (methocarbamol) submitted by Hikma Pharmaceuticals USA Inc.